Substance / Medication

Bleomycin sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

1
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Stereotactic Radiosurgery for Choriocarcinoma Brain Metastases: Illustrative Case Presentation and Systematic Review.
Akhavan-Sigari Amirhossein, Hori Yusuke S, Harary Paul M et al. · World Neurosurg · 2025
PMID: 39491621Meta-Analysis
Maternal and fetal outcomes of intraplacental choriocarcinoma complicated by fetomaternal hemorrhage: a systematic review.
Stabile Guglielmo, Gentile Roberta Marie, Carlucci Stefania et al. · J Matern Fetal Neonatal Med · 2023
PMID: 38010764Meta-Analysis
Non-myxoma neoplastic cerebral aneurysms: A systematic review.
Nussbaum Eric S, Torok Colin M, Khalil Zena M et al. · J Clin Neurosci · 2020
PMID: 33246908Meta-Analysis
Predictive factors of overall survival in primary intracranial pure choriocarcinoma.
Jiang Tao, Raynald, Yang Hongchao et al. · J Clin Neurosci · 2019
PMID: 30442453Meta-Analysis
Unusual clinical presentations of choriocarcinoma: A systematic review of case reports.
Mangla Mishu, Singla Deepak, Kaur Harpreet et al. · Taiwan J Obstet Gynecol · 2017
PMID: 28254207Meta-Analysis
Neoplastic cerebral aneurysm from metastatic tumor: a systematic review of clinical and treatment characteristics.
Zheng Jian, Zhang Jianmin · Clin Neurol Neurosurg · 2015
PMID: 25484302Meta-Analysis
Trophoblastic disease and choriocarcinoma.
Camilleri Graziella, Calleja-Aguis Jean, Said Edith · Eur J Surg Oncol · 2025
PMID: 39370364Review
Rare non-serous fallopian tube cancers: institutional experience and literature review.
Sumtsov Dmitrii, Sumtsov Georgyi, Hyriavenko Nataliia et al. · Wien Med Wochenschr · 2024
PMID: 38015299Review
Non-gestational choriocarcinoma: unraveling the similarities and distinctions from its gestational counterpart.
Mangla Mishu, Palo Seetu, Kanikaram Poojitha et al. · Int J Gynecol Cancer · 2024
PMID: 38123189Review
Intracardiac metastasis of gestational choriocarcinoma: a case report and literature review.
Gu Yu, Zheng Haoran, Xue Xiaowei et al. · BMC Pregnancy Childbirth · 2024
PMID: 38166849ReviewFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bleomycin sulfate (substance)
SNOMED CT
15660006
UMLS CUI
C0005739

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

8
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.